Autopsy report · NCT01701843

Cromoglicate in Mastocytosis

“prematurely terminated because of low recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

LEO Pharma

Sponsor type

Industry

Conditions

Mastocytosis

Interventions

Cromoglicate; Placebo

Participants

7

Sites

1

Countries

Germany

Trials that died the same way

• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
  “terminated due to slow recruitment” (85% match in meaning)
• Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic Patients
  “terminated due to very low recruitment rate (27 June 2006)” (83% match in meaning)
• Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
  “Terminated because of slow recruitment and lack of funding support” (82% match in meaning)
• Teens Coping With Parental Military Deployment
  “Terminated due to difficuly recruiting participants” (81% match in meaning)
• Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP
  “Terminated due to recruitment not meeting expectations.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.